Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
CONTROL试验的最终结果：降低HER2阳性早期乳腺癌患者奈拉替尼相关性腹泻发生率和严重程度的策略
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.12.003
Chan, Arlene; Ruiz-Borrego, Manuel; Marx, Gavin; Chien, A Jo; Rugo, Hope S; Brufsky, Adam; Thirlwell, Michael; Trudeau, Maureen; Bose, Ron; García-Sáenz, José A; Egle, Daniel; Pistilli, Barbara; Wassermann, Johanna; Cheong, Kerry A; Schnappauf, Benjamin; Semsek, Dieter; Singer, Christian F; Foruzan, Navid; DiPrimeo, Daniel; McCulloch, Leanne; Hurvitz, Sara A; Barcenas, Carlos H
